Founder Effects for ATM Gene Mutations in Italian Ataxia Telangiectasia Families

We screened ATM gene mutations in 104 Italian Ataxia‐Telangiectasia patients from 91 unrelated families (detection rate 90%) and found 21 recurrent mutations in 63 families. The majority (67%) of patients were compound heterozygotes, while 33% were homozygotes. To determine the existence of common haplotypes and potential founder effects, we analyzed five microsatellite markers within and flanking the ATM gene. Haplotype analysis was carried out in 48/63 families harbouring 16 of the 21 recurrent mutations. Forty different haplotypes were detected in the 48 A‐T families studied. We found that the majority of patients with the same recurrent mutation originated from the same geographical area. All but one recurrent mutation analyzed displayed a common haplotype suggesting a single origin that then spread to different geographical areas. The high number of different haplotypes does not allow the screening of ATM mutations by haplotype analysis alone in the Italian population. The finding of recurrent public mutations without founder effect suggests the existence of ‘mild’ hot spots of mutation located along the sequence of the ATM gene.

[1]  R. Gatti,et al.  Large Genomic Mutations within the ATM Gene Detected by MLPA, Including a Duplication of 41 kb from Exon 4 to 20 , 2007, Annals of human genetics.

[2]  B. Dallapiccola,et al.  DHPLC Screening of ATM Gene in Italian Patients Affected by Ataxia-Telangiectasia: Fourteen Novel ATM Mutations , 2006, Disease markers.

[3]  R. Gatti,et al.  ATM Gene Founder Haplotypes and Associated Mutations in Polish Families with Ataxia‐Telangiectasia , 2005, Annals of human genetics.

[4]  M. Lavin,et al.  ATM mutations, haplotype analysis, and immunological status of Russian patients with ataxia telangiectasia , 2005, Human mutation.

[5]  R. Gatti,et al.  ATM haplotypes and associated mutations in Iranian patients with ataxia–telangiectasia: recurring homozygosity without a founder haplotype , 2005, Human Genetics.

[6]  A. Lerner,et al.  Identification of two mutations for ataxia telangiectasia among the Druze community , 2004, Prenatal diagnosis.

[7]  Catarina D. Campbell,et al.  Five haplotypes account for fifty‐five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: Seven new mutations , 2004, American journal of medical genetics. Part A.

[8]  V. Sheffield,et al.  A high-density microsatellite map of the ataxia-telangiectasia locus , 1995, Human Genetics.

[9]  Catarina D. Campbell,et al.  Independent mutational events are rare in the ATM gene: Haplotype prescreening enhances mutation detection rate , 2003, Human mutation.

[10]  A. Børresen-Dale,et al.  Designing and implementing quality control for multi‐center screening of mutations in the ATM gene among women with breast cancer , 2003, Human mutation.

[11]  Y. Shiloh.  ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.

[12]  O. Sanal,et al.  Comprehensive scanning of the ATM gene with DOVAM‐S , 2003, Human mutation.

[13]  Catarina D. Campbell,et al.  ATM mutations on distinct SNP and STR haplotypes in ataxia‐telangiectasia patients of differing ethnicities reveal ancestral founder effects , 2003, Human mutation.

[14]  R. Gatti,et al.  NS22: a highly polymorphic complex microsatellite marker within the ATM gene. , 1999, American journal of medical genetics.

[15]  A. Børresen-Dale,et al.  Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: evidence for a founder effect , 1998, European Journal of Human Genetics.

[16]  M. Sasaki,et al.  Mutations of the ATM gene detected in Japanese ataxia-telangiectasia patients: possible preponderance of the two founder mutations 4612del165 and 7883del5 , 1998, Human Genetics.

[17]  Y. Shiloh,et al.  Genotype-phenotype relationships in ataxia-telangiectasia and variants. , 1998, American journal of human genetics.

[18]  A. Børresen-Dale,et al.  Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. , 1998, American journal of human genetics.

[19]  A. Broeks,et al.  ATM germline mutations in classical ataxia‐telangiectasia patients in the Dutch population , 1998, Human mutation.

[20]  R. Gatti,et al.  Diversity of ATM gene mutations detected in patients with ataxia‐telangiectasia , 1997, Human mutation.

[21]  Y. Shiloh,et al.  Ataxia-telangiectasia: founder effect among north African Jews. , 1996, Human molecular genetics.

[22]  H. Hoehn,et al.  New mutations in the ataxia telangiectasia gene , 1996, Human Genetics.

[23]  Y. Shiloh,et al.  Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. , 1996, American journal of human genetics.

[24]  Y. Shiloh,et al.  Predominance of null mutations in ataxia-telangiectasia. , 1996, Human molecular genetics.

[25]  N. Uhrhammer,et al.  Sublocalization of an ataxia-telangiectasia gene distal to D11S384 by ancestral haplotyping in Costa Rican families. , 1995, American journal of human genetics.

[26]  A. Børresen,et al.  Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. , 1995, American journal of human genetics.

[27]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[28]  F. Collins,et al.  Three dinucleotide repeat polymorphisms at the ataxia-telangiectasia locus. , 1994, Human molecular genetics.

[29]  L. Chessa,et al.  Ataxia-telangiectasia in Italy: genetic analysis. , 1994, International journal of radiation biology.